Ferring Pharmaceuticals

From Wikipedia, the free encyclopedia
Ferring Pharmaceuticals, Global Headquarters in St-Prex, Switzerland.

Ferring Pharmaceuticals is a multinational pharmaceutical company that specializes in the development and marketing of drugs for use in human medicine. It was founded by Frederik Paulsen Sr in Malmö, Sweden, in 1950, initially as the Nordiska Hormon Laboratoriet, renamed Ferring in 1954. A ferring in Frisian is a person from the island Föhr off the western coast of Germany. Mr. Paulsen's family originates from that island.

The first major breakthrough was the synthetic production of oxytocin and vasopressin in 1961. With further growth and expansion, the headquarters moved to Copenhagen, Denmark, and subsequently to Saint-Prex, Switzerland. In February 2012, the company held over 4,500 employees with manufacturing facilities in Europe, South America, China and was also building two new facilities in the US and in India. Products are used in reproductive health, gastroenterology, urology, orthopeadics and endocrinology.

In 2007 Alexandra, Countess of Frederiksborg joined the Danish board of directors of Ferring Pharmaceuticals.[1][2]

In 2012, Ferring Pharmaceuticals funded the Ferring Research Infertility and Gynaecology Grant

Notes and references

  1. ↑ "Countess Alexandra gets a million dollar job" (Grevinde Alexandra får millionjob), MSN Gossip, 26. september 2007
  2. ↑ "Alexandra in the board of directors of Ferring" (Alexandra i Ferrings bestyrelse), DR Nyheder, 26. september 2007

See also

External links

Wikimedia Commons has media related to Ferring Pharmaceuticals.


This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.